SCHEMBL8949897

SCHEMBL8949897

CNc1ccccc1.O=[PH](O)CP(=O)(O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.48
CA9 Q16790 2/20 0.42
CA12 O43570 1/20 0.42
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 1/20 0.38
NPSR1 Q6W5P4 1/20 0.36
MMP8 P22894 2/20 0.35
MMP14 P50281 2/20 0.35
CA14 Q9ULX7 2/20 0.35
FDPS P14324 2/20 0.35
CA2 P00918 1/20 0.35
ACP3 P15309 4/20 0.33
ANPEP P15144 1/20 0.33
CFTR P13569 1/20 0.33
HTT P42858 1/20 0.33
S1PR2 O95136 1/20 0.33
S1PR4 O95977 1/20 0.33
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Toluene SCHEMBL8949748 0.80 LMNA (0.42) TSHRCA12MEN1KMT2AALDH1A1
Phosphonic Acid SCHEMBL7796886 0.79 TSHR (0.70) TSHRKMT2AALDH1A1NAPRTHSD17B10
SCHEMBL8949885 0.77 TSHR (0.61) TSHRCA9CA12MEN1KMT2A
Methyl Phosphonate SCHEMBL9136984 0.77 TSHR (0.67) TSHRCA9CA12MEN1KMT2A
Methylphenylsulfide SCHEMBL8949917 0.76 KCNH2 (0.35) MEN1KMT2AALDH1A1ACP3CFTR
Methyl Phosphonate SCHEMBL9137329 0.75 TSHR (0.64) TSHRCA9CA12MEN1KMT2A
Ethane SCHEMBL8949916 0.72 KDM4E (0.35) FDPSCA2HSD17B10
SCHEMBL10340488 0.72 TSHR (0.58) TSHRKMT2AALDH1A1NAPRTHSD17B10
SCHEMBL7597199 0.72
Methylamine SCHEMBL9161547 0.70 LAP3 (0.35) ALDH1A1ANPEPHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5574024-A Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism EBETINO FRANK H (US) 1996-11-12 US disclosed
EP-0298553-B1 METHYLENE PHOSPHONOALKYLPHOSPHINATES, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM Norwich Eaton Pharmaceuticals, Inc. (US) 1992-01-15 EP disclosed
EP-0298553-A1 Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism Norwich Eaton Pharmaceuticals, Inc. (US) 1989-01-11 EP disclosed